You have 9 free searches left this month | for more free features.

Gastrointestinal cancer

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refractory Prostate Carcinoma Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Refractory Prostate Carcinoma
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Prostate Cancer Trial (Dasatinib)

Withdrawn
  • Prostate Cancer
  • (no location specified)
Feb 23, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (Bortezomib, Dexamethasone, Pelareorep)

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
  • +1 more
Aug 19, 2022

Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)

Active, not recruiting
  • Metastatic Prostate Cancer
  • Chandler, Arizona
  • +183 more
Nov 24, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +26 more
  • Biopsy
  • +5 more
  • Newark, Delaware
  • +52 more
Feb 2, 2023

Acceptability, Appropriateness, and Feasibility/Usability

Not yet recruiting
  • Metastatic Breast Cancer
  • End of Life
  • Clinician Qualitative Interview
  • Chapel Hill, North Carolina
    University of North Carolina
Jun 27, 2022

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

2D and 3D Primary Cell Cultures From Gastric and

Not yet recruiting
  • Gastric and Gastroesophageal Junction Cancer
    • Berlin, Germany
      Department of Anesthesiology and Operative Intensive Care Medici
    Sep 13, 2022

    Esophageal Cancer Associated Neoantigens

    Not yet recruiting
    • Esophageal Cancer
    • Neoantigen
    • ratio of predicted neoantigens
    • Ho Chi Minh City, Vietnam
      University Medical Center Ho Chi Minh City
    Aug 9, 2022

    Hematological Disorder Trial in Chapel Hill (Focus Group Discussions and Semi-structured Interviews, Training community lay

    Not yet recruiting
    • Hematological Disorder
    • Focus Group Discussions and Semi-structured Interviews
    • Training community lay navigators
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center, UNC
    Apr 12, 2023

    Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

    Not yet recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Ann Arbor, Michigan
      Rogel Cancer Center
    Jun 26, 2023

    Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Cairo, Egypt
      Ain Shams University Hospital
    Dec 20, 2022

    Increased Lymph Node Yield in Colorectal Cancer Synchronous

    Completed
    • Colorectal Cancer Stage IV
    • Lymph Node Yield
    • lymph node yield
    • Harbin, Heilongjiang, China
      Ethics and ethics of the Second Affiliated Hospital of Harbin Me
    Dec 19, 2022

    Persistent Atrial Fibrillation Trial in United Kingdom, United States (AtriCure EPi-Sense-AF Guided Coagulation System with

    Active, not recruiting
    • Persistent Atrial Fibrillation
    • AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax
    • Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering
    • Birmingham, Alabama
    • +26 more
    Jun 20, 2022

    NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

    Completed
    • Non-small Cell Lung Cancer
    • +9 more
    • Little Rock, Arkansas
    • +32 more
    Dec 12, 2022

    Cigarette Smoking Trial in Vientiane (Nicotine patch, Self-help materials (to support smoking cessation), Smartphone-based

    Recruiting
    • Cigarette Smoking
    • Nicotine patch
    • +2 more
    • Vientiane, Lao People's Democratic Republic
    • +1 more
    Jun 17, 2022

    Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)

    Recruiting
    • Gastric or Gastroesophageal Junction Adenocarcinoma
    • PD-1 inhibitor
    • Guangzhou, China
      Sun Yat-sen University Cancer Center
    Aug 9, 2023

    Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)

    Completed
    • Heart Failure
    • +4 more
    • Darbepoetin alfa
    • Placebo
    • Birmingham, Alabama
    • +753 more
    Oct 31, 2021

    ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • SIGNATERA™ ctDNA testing
    • Fairfax, Virginia
      Inova Schar Cancer Institute
    Oct 26, 2022

    NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Telisotuzumab Vedotin
    • +4 more
    • (no location specified)
    Oct 17, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Yuma, Arizona
    • +5 more
    May 25, 2022

    Lung Cancer Trial (bronchoscope)

    Not yet recruiting
    • Lung Cancer
    • bronchoscope
    • (no location specified)
    Aug 8, 2023

    Response to Anti-Cancer Therapy

    Recruiting
    • Carcinomas (Including Squamous Cell and Adenocarcinoma)
    • Neoplasms
    • blood draw
    • Stanford, California
      Stanford University School of Medicine
    Mar 15, 2022

    FTT PET/CT in Metastatic Prostate Cancer

    Not yet recruiting
    • Prostate Cancer Metastatic
    • Philadelphia, Pennsylvania
      University of Pennsylvania Hospital
    Jul 13, 2022

    Breast Cancer Trial in Houston, San Juan (Baseline Fitness Test, Questionnaires, Individualized Exercise Program)

    Active, not recruiting
    • Breast Cancer
    • Baseline Fitness Test
    • +3 more
    • Houston, Texas
    • +1 more
    Oct 11, 2022